NVAXNovavax, Inc. Stock Analysis

Exchange: NASDAQ | Sector: Healthcare | Industry: Biotechnology

Current Price: $7.70 (+3.77% today)

Market Cap: $1.25B

P/E (TTM): 2.80

Relative Strength (RS%): 97

-35.7% from 52-week high

Back to Scanner

NVAX

NASDAQRS 97Score 25

Novavax, Inc.

HealthcareBiotechnology$1.25B
$7.70
+3.8% ($0.29)
-35.7% from 52W High
P/E (TTM)
2.80
Fwd P/E
PEG
Analyst Upside
EPS Growth
Gross Margin
93.3%
ROE
-546.2%
D/E
-1.95
Div Yield
0.0%
Avg Volume
4.7M

Price Chart

Key Levels

SMA 200
$8.03
SMA 50
$9.37
Price
$7.70
52W High
$11.98

Setup Radar

0/8 passing
📈
CAN SLIMO'Neil
Near highs + RS ≥ 80
🎯
VCPMinervini
Within 25% high, RS ≥ 70, > 200 SMA
📊
Trend TemplateMinervini
> 50 & 200 SMA, RS ≥ 70, near high
🚀
Stage 2Weinstein
RS ≥ 60, > 200 SMA
📦
Darvas BoxDarvas
Near highs, > 200 SMA
Earnings MomentumGrowth
EPS growth ≥ 20%
🔍
PEG HunterLynch
PEG < 1.5, EPS growth ≥ 15%
🎪
Analyst UpsideConsensus
Target upside ≥ 15%, 1+ analyst